MetaCap

Tenaya Therapeutics Insider Trades

NASDAQ: TNYAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.5803+0.0361 (+6.63%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
35 · $5.98M
Shares bought / sold
0 / 9.47M
Net activity
Net selling $6.0 million

Tenaya Therapeutics insider activity

Over the last 12 months, Tenaya Therapeutics insiders reported 40 transactions on SEC Form 4: 0 open-market purchases and 35 sales. Insiders bought $0 and sold $6.0 million worth of stock, for net insider selling of $6.0 million. The largest seller was COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter, with $5.9 million in reported sales.

The most recent filing shows Ali Faraz (Chief Executive Officer) reporting a transaction in 122,000 shares on Sep 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TNYA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TNYA insider transactions

Tenaya Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 10, 2026Tingley WhittemoreChief Medical OfficerAward49,000—Form 4
Sep 10, 2026Ali FarazChief Executive OfficerAward122,000—Form 4
Aug 17, 2026Tingley WhittemoreChief Medical OfficerSale2,279$1.62KForm 4
Aug 17, 2026Tingley WhittemoreChief Medical OfficerSale1,871$1.33KForm 4
Aug 17, 2026Tingley WhittemoreChief Medical OfficerSale1,637$1.16KForm 4
Aug 17, 2026Tingley WhittemoreChief Medical OfficerSale1,637$1.16KForm 4
Aug 17, 2026Ali FarazChief Executive OfficerSale7,406$5.26KForm 4
Aug 17, 2026Ali FarazChief Executive OfficerSale5,020$3.56KForm 4
Aug 17, 2026Ali FarazChief Executive OfficerSale3,969$2.82KForm 4
Aug 17, 2026Ali FarazChief Executive OfficerSale5,837$4.14KForm 4
May 18, 2026Tingley WhittemoreChief Medical OfficerSale3,121$2.48KForm 4
May 18, 2026Higa TomohiroSVP, FinanceSale1,485$1.18KForm 4
May 18, 2026Ali FarazChief Executive OfficerSale3,390$2.69KForm 4
Feb 25, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale1,862,545$1.05MForm 4
Feb 25, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale1,649,281$927.56KForm 4
Feb 24, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale349,212$214.87KForm 4
Feb 24, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale309,228$190.27KForm 4
Feb 23, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale162,291$96.92KForm 4
Feb 23, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale143,709$85.82KForm 4
Feb 20, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale277,769$170.80KForm 4
Feb 20, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale245,965$151.24KForm 4
Feb 17, 2026Tingley WhittemoreChief Medical OfficerSale1,876$1.21KForm 4
Feb 17, 2026Tingley WhittemoreChief Medical OfficerSale1,642$1.06KForm 4
Feb 17, 2026Tingley WhittemoreChief Medical OfficerSale1,642$1.06KForm 4
Feb 17, 2026Ali FarazChief Executive OfficerSale5,032$3.24KForm 4
Feb 17, 2026Ali FarazChief Executive OfficerSale3,979$2.56KForm 4
Feb 17, 2026Ali FarazChief Executive OfficerSale5,851$3.76KForm 4
Feb 17, 2026Higa TomohiroSVP, FinanceSale2,022$1.30KForm 4
Feb 17, 2026Higa TomohiroSVP, FinanceSale836$537.88Form 4
Feb 17, 2026Higa TomohiroSVP, FinanceSale611$393.12Form 4
Feb 11, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale2,151,458$1.46MForm 4
Feb 11, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale1,905,115$1.30MForm 4
Feb 10, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale182,295$148.77KForm 4
Feb 10, 2026COLUMN GROUP III GP, LP & COLUMN GROUP III, LP & COLUMN GROUP III-A, LP & Column Group Opportunity III, LP & Column Group Opportunity III GP, LP & TCG Opportunity III GP, LLC & Kutzkey Tim & Svennilson Peter10% OwnerSale161,422$131.74KForm 4
Feb 3, 2026Ali FarazChief Executive OfficerAward158,600—Form 4
Feb 3, 2026Tingley WhittemoreChief Medical OfficerAward48,750—Form 4
Feb 3, 2026Higa TomohiroSVP, FinanceAward29,250—Form 4
Nov 17, 2025Ali FarazChief Executive OfficerSale3,126$4.16KForm 4
Nov 17, 2025Higa TomohiroSVP, FinanceSale1,367$1.82KForm 4
Nov 17, 2025Tingley WhittemoreChief Medical OfficerSale2,877$3.83KForm 4
Aug 18, 2025Ali FarazChief Executive OfficerSale4,920$6.16KForm 4
Aug 18, 2025Ali FarazChief Executive OfficerSale3,893$4.88KForm 4
Aug 18, 2025Ali FarazChief Executive OfficerSale5,720$7.17KForm 4
Aug 18, 2025Tingley WhittemoreChief Medical OfficerSale1,837$2.30KForm 4
Aug 18, 2025Tingley WhittemoreChief Medical OfficerSale1,608$2.01KForm 4
Aug 18, 2025Tingley WhittemoreChief Medical OfficerSale1,608$2.01KForm 4
Aug 18, 2025Higa TomohiroSVP, FinanceSale1,722$2.16KForm 4
Aug 18, 2025Higa TomohiroSVP, FinanceSale717$898.40Form 4
Aug 18, 2025Higa TomohiroSVP, FinanceSale523$655.32Form 4
May 16, 2025Tingley WhittemoreChief Medical OfficerSale2,937$1.30KForm 4
May 16, 2025Higa TomohiroSVP, FinanceSale1,390$615.35Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related